Publications by authors named "L C Immergluck"
Article Synopsis
- - The study assessed the effectiveness of a COVID-19 Sanofi booster vaccine by measuring neutralizing antibody levels in COVAIL recipients as a predictor of COVID-19 risk.
- - Higher levels of antibody titers were found to be associated with a lower risk of COVID-19, indicated by adjusted hazard ratios of 0.30 and 0.25 for different titer measurements.
- - An increase of 10-fold in the weighted average titer substantially reduced the risk, suggesting that higher antibody levels can offer better protection against the virus.
This retrospective cohort study drawing data from 48 major tertiary children's hospitals found heterogeneity in the diagnosis and management of congenital syphilis despite Centers for Disease Control and Prevention guideline recommendations. The noted overall rise in the number of congenital syphilis cases mirrors the nationwide increase.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 infection in young adults aged 18-29 who had never been infected or vaccinated before.
- Over 1,149 participants received the vaccine, and the results showed a 52.6% efficacy against infection and 71.0% efficacy against symptomatic COVID-19, primarily due to the Delta variant.
- Despite the positive findings, the incidence of infection was higher in a separate group that declined vaccination, indicating that other factors also played a role in infection risk.
(1) Background: With increasing international travel and mass population displacement due to war, famine, climate change, and immigration, pathogens, such as (), can also spread across borders. Methicillin-resistant (MRSA) most commonly causes skin and soft tissue infections (SSTIs), as well as more invasive infections. One clonal strain, USA300, originating in the United States, has spread worldwide.
View Article and Find Full Text PDF